Global Blood Therapeutics, Inc.
Methods of treatment

Last updated:

Abstract:

This disclosure relates to use of certain aldehyde compounds for treating pulmonary fibrosis, hypoxia, and connective tissue and autoimmune disease such as scleroderma, lupus, arthritis and related conditions in a mammal.

Status:
Grant
Type:

Utility

Filling date:

16 May 2018

Issue date:

30 Jun 2020